[Aldosterone and renin in liver cirrhosis with ascites]. 1977

H Vetter, and W Vetter, and R Beckerhoff, and K Glänzer, and J Furrer, and C Hahn, and R Kolloch, and F Krück, and K Kutz, and W Siegenthaler, and F Witassek

Supine plasma aldosterone and plasma renin activity were determined in patients with cirrhosis of the liver and ascites (n = 10). Most of the patients initially showed an increase in plasma aldosterone and plasma renin activity. However, values within the normal range were observed (plasma aldosterone, n = 3; plasma renin activity, n = 4). In the ascitic fluid renin activity could not be detected, whereas aldosterone concentrations correlated significantly with the respective plasma levels (r = 0.8, p less than 0.01). During therapy with spironolactone alone (n =2) or in combination with furosemide (n = 4), diuresis and natriuresis showed no correlation with changes in plasma aldosterone and/or plasma renin activity. Our results suggest that other factors than renin and aldosterone secretion may be important in the formation of ascites in patients with cirrhosis of the liver. In addition, the inverse correlation between mean arterial blood pressure and plasma renin activity (r = -0.65, p less than 0.05) found in our patients supports the assumption that the increase in renin secretion is probably induced by changes in (renal) hemodynamics.

UI MeSH Term Description Entries
D008103 Liver Cirrhosis Liver disease in which the normal microcirculation, the gross vascular anatomy, and the hepatic architecture have been variably destroyed and altered with fibrous septa surrounding regenerated or regenerating parenchymal nodules. Cirrhosis, Liver,Fibrosis, Liver,Hepatic Cirrhosis,Liver Fibrosis,Cirrhosis, Hepatic
D008104 Liver Cirrhosis, Alcoholic FIBROSIS of the hepatic parenchyma due to chronic excess ALCOHOL DRINKING. Alcoholic Cirrhosis,Hepatic Cirrhosis, Alcoholic,Alcoholic Hepatic Cirrhosis,Alcoholic Liver Cirrhosis
D012083 Renin A highly specific (Leu-Leu) endopeptidase that generates ANGIOTENSIN I from its precursor ANGIOTENSINOGEN, leading to a cascade of reactions which elevate BLOOD PRESSURE and increase sodium retention by the kidney in the RENIN-ANGIOTENSIN SYSTEM. The enzyme was formerly listed as EC 3.4.99.19. Angiotensin-Forming Enzyme,Angiotensinogenase,Big Renin,Cryorenin,Inactive Renin,Pre-Prorenin,Preprorenin,Prorenin,Angiotensin Forming Enzyme,Pre Prorenin,Renin, Big,Renin, Inactive
D005665 Furosemide A benzoic-sulfonamide-furan. It is a diuretic with fast onset and short duration that is used for EDEMA and chronic RENAL INSUFFICIENCY. Frusemide,Fursemide,Errolon,Frusemid,Furanthril,Furantral,Furosemide Monohydrochloride,Furosemide Monosodium Salt,Fusid,Lasix
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000450 Aldosterone A hormone secreted by the ADRENAL CORTEX that regulates electrolyte and water balance by increasing the renal retention of sodium and the excretion of potassium. Aldosterone, (+-)-Isomer,Aldosterone, (11 beta,17 alpha)-Isomer
D001201 Ascites Accumulation or retention of free fluid within the peritoneal cavity.
D013148 Spironolactone A potassium sparing diuretic that acts by antagonism of aldosterone in the distal renal tubules. It is used mainly in the treatment of refractory edema in patients with congestive heart failure, nephrotic syndrome, or hepatic cirrhosis. Its effects on the endocrine system are utilized in the treatments of hirsutism and acne but they can lead to adverse effects. (From Martindale, The Extra Pharmacopoeia, 30th ed, p827) Spirolactone,Aldactone,Aldactone A,Aquareduct,Duraspiron,Espironolactona Alter,Espironolactona Mundogen,Flumach,Frumikal,Jenaspiron,Novo-Spiroton,Practon,SC-9420,Spiractin,Spiro L.U.T.,Spiro Von Ct,Spirobeta,Spirogamma,Spirolang,Spirono-Isis,Spironone,Spirospare,Veroshpiron,Verospiron,Verospirone,Ct, Spiro Von,Novo Spiroton,NovoSpiroton,SC 9420,SC9420,Spirono Isis,Von Ct, Spiro

Related Publications

H Vetter, and W Vetter, and R Beckerhoff, and K Glänzer, and J Furrer, and C Hahn, and R Kolloch, and F Krück, and K Kutz, and W Siegenthaler, and F Witassek
February 1979, European journal of clinical investigation,
H Vetter, and W Vetter, and R Beckerhoff, and K Glänzer, and J Furrer, and C Hahn, and R Kolloch, and F Krück, and K Kutz, and W Siegenthaler, and F Witassek
April 1986, European journal of clinical investigation,
H Vetter, and W Vetter, and R Beckerhoff, and K Glänzer, and J Furrer, and C Hahn, and R Kolloch, and F Krück, and K Kutz, and W Siegenthaler, and F Witassek
January 1989, Terapevticheskii arkhiv,
H Vetter, and W Vetter, and R Beckerhoff, and K Glänzer, and J Furrer, and C Hahn, and R Kolloch, and F Krück, and K Kutz, and W Siegenthaler, and F Witassek
November 1986, Revista espanola de las enfermedades del aparato digestivo,
H Vetter, and W Vetter, and R Beckerhoff, and K Glänzer, and J Furrer, and C Hahn, and R Kolloch, and F Krück, and K Kutz, and W Siegenthaler, and F Witassek
February 1967, Sovetskaia meditsina,
H Vetter, and W Vetter, and R Beckerhoff, and K Glänzer, and J Furrer, and C Hahn, and R Kolloch, and F Krück, and K Kutz, and W Siegenthaler, and F Witassek
January 1990, Minerva medica,
H Vetter, and W Vetter, and R Beckerhoff, and K Glänzer, and J Furrer, and C Hahn, and R Kolloch, and F Krück, and K Kutz, and W Siegenthaler, and F Witassek
January 1983, Przeglad lekarski,
H Vetter, and W Vetter, and R Beckerhoff, and K Glänzer, and J Furrer, and C Hahn, and R Kolloch, and F Krück, and K Kutz, and W Siegenthaler, and F Witassek
December 1984, Gastroenterology,
H Vetter, and W Vetter, and R Beckerhoff, and K Glänzer, and J Furrer, and C Hahn, and R Kolloch, and F Krück, and K Kutz, and W Siegenthaler, and F Witassek
July 1981, Annals of internal medicine,
H Vetter, and W Vetter, and R Beckerhoff, and K Glänzer, and J Furrer, and C Hahn, and R Kolloch, and F Krück, and K Kutz, and W Siegenthaler, and F Witassek
December 2008, European journal of clinical investigation,
Copied contents to your clipboard!